CD8A and breast cancer: Authors concluded that it is not only the presence of CD8 T cells, but rather T cell clonality, T cell subset distribution, co-inhibition and antigen presentation that reflect occurrence of a CD8 T cell response in BC subtypes, providing a rational for subtype-specific combination immune therapies.